NanoBio (Ann Arbor, MI), a clinical-stage biotechnology company focused on anti-infective intranasal & intramuscular vaccines for influenza, closed an $11M Series C financing. Participants include Perseus and Venture Investors.

Tactile Systems Technology (Minneapolis, MN), a commercial-stage medical device company focused on at-home lymphedema treatments, closed a $10.4M Series B financing. Participants include Radius Ventures and Galen Partners. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem Request Collective IP Account Access HERE

Strand Diagnostics (Indianapolis, IN) a commercial-stage molecular diagnostics company focused on DNA screening of breast and prostate biopsy samples and patient DNA for molecular cancer diagnosis verification, closed a $30M Series A financing. Participants include NantWorks. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

ViewRay (Oakwood Village, OH) a clinical-stage medical device company focused on MRI-guided radiation therapy system for the treatment of various cancers, closed a $26.3M Series C financing, bringing the total round to $45M. Participants include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed and Siemens Venture Capital.

CardioInsight Technologies (Cleveland, OH) a commercial-stage medical device company focused on non-invasive electrocardiographic mapping technology, closed a $7.5 Series C financing. Participants were not disclosed.

Pulse Therapeutics (St. Louis, MO) a development-stage medical device company focused on vascular drug delivery device for blood clots in stroke patients , closed a $3.1M Series B financing. Participants include BioGenerator.

CytoPherx (Ann Arbor, MI) a clinical-stage medical device company focused on dialysis filters to sequester and deactivate leukocytes in the patient’s blood system for acute renal failure, closed a $34M Series C financing. Participants include Early Stage Partners, Onset Ventures and Capital Midwest Fund.

Pulse Therapeutics (St. Louis, MO) a development-stage medical device company focused on vascular drug delivery device for blood clots in stroke patients, closed a $3.1M Series B financing. Participants include BioGenerator.

CytoPherx (Ann Arbor, MI) a clinical-stage medical device company focused on dialysis filters to sequester and deactivate leukocytes in the patient’s blood system for acute renal failure, closed a $34M Series C financing. Participants include Early Stage Partners, Onset Ventures and Capital Midwest Fund.

Akebia Therapeutics (Cincinnati, OH) a preclinical-stage small molecule company focused on anemia, vascular disorders and angiogenesis, closed a $4.1M Series B financing. Participants include Novartis Bioventures, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners, Sigvion Capital and AgeChem Venture Fund.

BioAmber (Plymouth, MN) a commercial-stage biofuel company focused on the production bio-succinic acid and other bio-based chemicals, closed a $30M Series C financing. Participants include Naxos Capital, Sofinnova Partners, Mitsui & Co. and the Cliffton Group.

Apnex Medical (St Paul, MN) a clinical-stage medical device company focused on implantable treatments for sleep apnea, closed a $20M Series C financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners.

Advanced ICU Care (St Louis, MO) a commercial-stage Tele-ICU medical services company focused on bedside critical care, closed a $8M Series D financing. Participants include Trident Capital, Versant Ventures, Arboretum Ventures and Catalyst Capital.